ATF3 and peripheral nerve injury: AAV-mediated delivery is capable of highly specific, efficient and long-lasting expression of GluCl in sensory neurons in vivo without deficits in cutaneous afferent innervation or upregulation of the injury marker ATF3 and can normalize pain-related behaviour following peripheral nerve injury in a reproducible and reversible fashion.